We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $807M
1-Year Est. Return 65.46%
This Fund
S&P 500
This Quarter Est. Return
+29.96%
1 Year Est. Return
+65.46%
3 Year Est. Return
+245.67%
5 Year Est. Return
10 Year Est. Return
AUM
$490M
AUM Growth
+$226M
Cap. Flow
+$149M
Cap. Flow %
30.35%
Top 10 Hldgs %
35.67%
Holding
392
New
133
Increased
17
Reduced
62
Closed
87

Top Sells

Rank Stock Value
1
CZZ
Cosan Limited
CZZ
+$3.5M
2
WNS
WNS Holdings
WNS
+$3.26M
3
TDG icon
TransDigm Group
TDG
+$2.98M
4
MSCI icon
MSCI
MSCI
+$2.66M
5
CRH icon
CRH
CRH
+$2.63M

Sector Composition

Rank Sector Weight
1 Healthcare 19.12%
2 Technology 14.43%
3 Materials 5.84%
4 Consumer Discretionary 5.38%
5 Consumer Staples 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEL icon
201
XPEL
XPEL
$1.18B
$12K ﹤0.01%
741
BCEL
202
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$12K ﹤0.01%
+541
New +$9.56K
VAPO
203
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$12K ﹤0.01%
+38
New +$8.01K
AGTC
204
DELISTED
Applied Genetic Technologies Corporation
AGTC
$12K ﹤0.01%
+2,050
New +$9.39K
ECOM
205
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$12K ﹤0.01%
+730
New +$8.44K
KDMN
206
DELISTED
Kadmon Holdings, Inc.
KDMN
$12K ﹤0.01%
2,421
ACLS icon
207
Axcelis
ACLS
$4.12B
$11K ﹤0.01%
396
BFC icon
208
Bank First Corp
BFC
$1.67B
$11K ﹤0.01%
177
CEVA icon
209
CEVA Inc
CEVA
$1.01B
$11K ﹤0.01%
+305
New +$9.78K
CLAR icon
210
Clarus
CLAR
$125M
$11K ﹤0.01%
992
CRBP icon
211
Corbus Pharmaceuticals
CRBP
$170M
$11K ﹤0.01%
+45
New +$9.09K
DJCO icon
212
Daily Journal
DJCO
$792M
$11K ﹤0.01%
40
EGAN icon
213
eGain
EGAN
$176M
$11K ﹤0.01%
+1,023
New +$9.31K
FF icon
214
Future Fuel
FF
$204M
$11K ﹤0.01%
+942
New +$11.1K
GLDD
215
DELISTED
Great Lakes Dredge & Dock
GLDD
$11K ﹤0.01%
1,223
IMKTA icon
216
Ingles Markets
IMKTA
$1.63B
$11K ﹤0.01%
261
MIRM icon
217
Mirum Pharmaceuticals
MIRM
$6.89B
$11K ﹤0.01%
+550
New +$9.19K
PETS icon
218
PetMed Express
PETS
$42.5M
$11K ﹤0.01%
311
SPRO icon
219
Spero Therapeutics
SPRO
$68.9M
$11K ﹤0.01%
+850
New +$9.54K
SPTN
220
DELISTED
SpartanNash
SPTN
$11K ﹤0.01%
+538
New +$9.65K
SYRE icon
221
Spyre Therapeutics
SYRE
$8.87B
$11K ﹤0.01%
+46
New +$8.76K
UFPT icon
222
UFP Technologies
UFPT
$1.84B
$11K ﹤0.01%
255
UTZ icon
223
Utz Brands
UTZ
$1.25B
$11K ﹤0.01%
784
WRAP icon
224
Wrap Technologies
WRAP
$94.8M
$11K ﹤0.01%
+1,091
New +$6.53K
TBCH
225
Turtle Beach Corp
TBCH
$239M
$11K ﹤0.01%
+719
New +$7.42K

Similar funds

Dorsey Wright & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Dorsey Wright & Associates held 392 positions worth $490M, up 86% from $264M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Dorsey Wright & Associates deployed $149M of net new capital in Q2 2020, opening 133 new positions and adding to 17 existing holdings. Its largest new stake was Invesco QQQ Trust: 247,110 shares worth $61.9M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was MSCI, an estimated $2.66M trimmed.

  • Dorsey Wright & Associates's largest Q2 2020 buy was Invesco QQQ Trust: 247,110 shares worth $61.9M.
  • Dorsey Wright & Associates added most to iShares MSCI USA Momentum Factor ETF in Q2 2020, an estimated $21M increase.
  • Dorsey Wright & Associates's biggest Q2 2020 reduction was MSCI, cutting an estimated $2.66M.
  • Dorsey Wright & Associates fully exited Cosan Limited in Q2 2020, selling an estimated $3.5M.
  • Dorsey Wright & Associates's ten largest holdings make up 36% of its $490M portfolio in Q2 2020.
  • Dorsey Wright & Associates opened 133 new positions and closed 87 in Q2 2020.
  • Dorsey Wright & Associates's portfolio value rose 86% quarter-over-quarter to $490M.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.